View Archive »
About The Cover
MicroRNA-146a constrains multiple parameters of intestinal immunity and increases susceptibility to DSS colitis. See Runtsch et al.
|
|
Table of Contents
Editorial
|
| Snitrosylation and MSCmediated body composition |
|
https://doi.org/10.18632/oncotarget.5672
|
| 28517-28518 |
|
| Type I collagen fibrils: an inducer of invadosomes |
|
https://doi.org/10.18632/oncotarget.5804
|
| 28519-28520 |
Editorial: Immunology
|
| Neuroimmune signaling by extracellular vesicles |
|
https://doi.org/10.18632/oncotarget.5249
|
| 28521-28522 |
|
| Enhancing immunity by engineering DAMPs |
|
https://doi.org/10.18632/oncotarget.5251
|
| 28523-28524 |
|
| STAT2directed pathogen responses |
|
https://doi.org/10.18632/oncotarget.5266
|
| 28525-28526 |
|
| Crosspresentation of antigens by dendritic cells: role of autophagy |
|
https://doi.org/10.18632/oncotarget.5268
|
| 28527-28528 |
|
| Protective CD8+ T cell memory without help |
|
https://doi.org/10.18632/oncotarget.5449
|
| 28529-28530 |
|
| MCPIP: a key player in macrophage polarization |
|
https://doi.org/10.18632/oncotarget.5451
|
| 28531-28532 |
|
| Defensins versus pathogens: an unfolding story |
|
https://doi.org/10.18632/oncotarget.5109
|
| 28533-28534 |
|
| Quelling an innate response to dsRNA |
|
https://doi.org/10.18632/oncotarget.5110
|
| 28535-28536 |
|
| DNAM1: would the real natural killer cell please stand up |
|
https://doi.org/10.18632/oncotarget.5952
|
| 28537-28538 |
Research Papers: Immunology
|
| A novel human truncated IL12rβ1Fc fusion protein ameliorates experimental autoimmune encephalomyelitis via specific binding of p40 to inhibit Th1 and Th17 cell differentiation |
|
https://doi.org/10.18632/oncotarget.5164
|
| 28539-28555 |
|
| MicroRNA146a constrains multiple parameters of intestinal immunity and increases susceptibility to DSS colitis |
|
https://doi.org/10.18632/oncotarget.5597
|
| 28556-28572 |
|
| Activation of human mast cells by retrocyclin and protegrin highlight their immunomodulatory and antimicrobial properties |
|
https://doi.org/10.18632/oncotarget.5611
|
| 28573-28587 |
|
| CD8+ T cells undergo activation and programmed death1 repression in the liver of aged Ae2ab–/– mice favoring autoimmune cholangitis |
|
https://doi.org/10.18632/oncotarget.5665
|
| 28588-28606 |
|
| Nickel chloride NiCl2caused inflammatory responses via activation of NFκB pathway and reduction of antiinflammatory mediator expression in the kidney |
|
https://doi.org/10.18632/oncotarget.5759
|
| 28607-28620 |
|
| PDGF upregulates CLEC2 to induce T regulatory cells |
|
https://doi.org/10.18632/oncotarget.5765
|
| 28621-28632 |
|
| Antigenspecific human NKT cells from tuberculosis patients produce IL21 to help B cells for the production of immunoglobulins |
|
https://doi.org/10.18632/oncotarget.5764
|
| 28633-28645 |
|
| A genome wide transcriptional model of the complex response to preTCR signalling during thymocyte differentiation |
|
https://doi.org/10.18632/oncotarget.5796
|
| 28646-28660 |
|
| Vanadium toxicity in the thymic development |
|
https://doi.org/10.18632/oncotarget.5798
|
| 28661-28677 |
|
| Caffeine affects the biological responses of human hematopoietic cells of myeloid lineage via downregulation of the mTOR pathway and xanthine oxidase activity |
|
https://doi.org/10.18632/oncotarget.5212
|
| 28678-28692 |
Reviews
|
| Molecular and clinical profiles of syndecan1 in solid and hematological cancer for prognosis and precision medicine |
|
https://doi.org/10.18632/oncotarget.4981
|
| 28693-28715 |
|
| Timing and extent of response in colorectal cancer: critical review of current data and implication for future trials |
|
https://doi.org/10.18632/oncotarget.4747
|
| 28716-28730 |
|
| Vav1: A Dr Jekyll and Mr Hyde protein – good for the hematopoietic system bad for cancer |
|
https://doi.org/10.18632/oncotarget.5086
|
| 28731-28742 |
Research Papers
|
| Genetic interaction of P2X7 receptor and VEGFR2 polymorphisms identifies a favorable prognostic profile in prostate cancer patients |
|
https://doi.org/10.18632/oncotarget.4926
|
| 28743-28754 |
|
| Triplelayer dissection of the lung adenocarcinoma transcriptome – regulation at the gene transcript and exon levels |
|
https://doi.org/10.18632/oncotarget.4810
|
| 28755-28773 |
|
| New therapeutic strategies in neuroblastoma: combined targeting of a novel tyrosine kinase inhibitor and liposomal siRNAs against ALK |
|
https://doi.org/10.18632/oncotarget.4342
|
| 28774-28789 |
|
| The prognosis was poorer in colorectal cancers that expressed both VEGF and PROK1No correlation coefficient between VEGF and PROK1 |
|
https://doi.org/10.18632/oncotarget.4744
|
| 28790-28799 |
|
| Primary tumor and metastasisderived colon cancer cells differently modulate connexin expression and function in human capillary endothelial cells |
|
https://doi.org/10.18632/oncotarget.4894
|
| 28800-28815 |
|
| FANCJ protein is important for the stability of FANCD2/FANCI proteins and protects them from proteasome and caspase3 dependent degradation |
|
https://doi.org/10.18632/oncotarget.5006
|
| 28816-28832 |
|
| TAK1 and IKK2 novel mediators of SCFinduced signaling and potential targets for cKitdriven diseases |
|
https://doi.org/10.18632/oncotarget.5008
|
| 28833-28850 |
|
| Licochalcone A induces autophagy through PI3K/Akt/mTOR inactivation and autophagy suppression enhances Licochalcone Ainduced apoptosis of human cervical cancer cells |
|
https://doi.org/10.18632/oncotarget.4767
|
| 28851-28866 |
|
| MiR21 mediates sorafenib resistance of hepatocellular carcinoma cells by inhibiting autophagy via the PTEN/Akt pathway |
|
https://doi.org/10.18632/oncotarget.4814
|
| 28867-28881 |
|
| MiR1207 overexpression promotes cancer stem cell–like traits in ovarian cancer by activating the Wnt/βcatenin signaling pathway |
|
https://doi.org/10.18632/oncotarget.4921
|
| 28882-28894 |
|
| PI3K/AKT signaling modulates transcriptional expression of EWS/FLI1 through specificity protein 1 |
|
https://doi.org/10.18632/oncotarget.5000
|
| 28895-28910 |
|
| Rigorous optimization and validation of potent RNA CAR T cell therapy for the treatment of common epithelial cancers expressing folate receptor |
|
https://doi.org/10.18632/oncotarget.5029
|
| 28911-28928 |
|
| Identification and characterization of RET fusions in advanced colorectal cancer |
|
https://doi.org/10.18632/oncotarget.4325
|
| 28929-28937 |
|
| Inhibition of 13cis retinoic acidinduced gene expression of reactiveresistance genes by thalidomide in glioblastoma tumours in vivo |
|
https://doi.org/10.18632/oncotarget.4727
|
| 28938-28948 |
|
| Loss of miR200b promotes invasion via activating the Kindlin2/integrin β1/AKT pathway in esophageal squamous cell carcinoma: An Ecadherinindependent mechanism |
|
https://doi.org/10.18632/oncotarget.5027
|
| 28949-28960 |
|
| Stat5deficient hematopoiesis is permissive for Mycinduced Bcell leukemogenesis |
|
https://doi.org/10.18632/oncotarget.5009
|
| 28961-28972 |
|
| Metformin represses cancer cells via alternate pathways in Ncadherin expressing vs Ncadherin deficient cells |
|
https://doi.org/10.18632/oncotarget.5023
|
| 28973-28987 |
|
| Changes in the gene expression of cocultured human fibroblast cells and osteosarcoma cells: the role of microenvironment |
|
https://doi.org/10.18632/oncotarget.4902
|
| 28988-28998 |
|
| A novel immune resistance mechanism of melanoma cells controlled by the ADAR1 enzyme |
|
https://doi.org/10.18632/oncotarget.4905
|
| 28999-29015 |
|
| Enhanced cell migration and apoptosis resistance may underlie the association between high SERPINE1 expression and poor outcome in head and neck carcinoma patients |
|
https://doi.org/10.18632/oncotarget.5032
|
| 29016-29033 |
|
| IL1β produced by aggressive breast cancer cells is one of the factors that dictate their interactions with mesenchymal stem cells through chemokine production |
|
https://doi.org/10.18632/oncotarget.4732
|
| 29034-29047 |
|
| HBV preS2 promotes the expression of TAZ via miRNA3383p to enhance the tumorigenesis of hepatocellular carcinoma |
|
https://doi.org/10.18632/oncotarget.4804
|
| 29048-29059 |
|
| TRIPBr1 oncoprotein inhibits autophagy apoptosis and necroptosis under nutrient/serumdeprived condition |
|
https://doi.org/10.18632/oncotarget.5072
|
| 29060-29075 |
|
| PDK1 induces JunB EMT cell migration and invasion in human gallbladder cancer |
|
https://doi.org/10.18632/oncotarget.4931
|
| 29076-29086 |
|
| Chromosomal catastrophe is a frequent event in clinically insignificant prostate cancer |
|
https://doi.org/10.18632/oncotarget.4900
|
| 29087-29096 |
|
| Suppressor of cytokine signaling 1 gene mutation status as a prognostic biomarker in classical Hodgkin lymphoma |
|
https://doi.org/10.18632/oncotarget.4829
|
| 29097-29110 |
|
| The importance of microenvironment: the role of CCL8 in metastasis formation of melanoma |
|
https://doi.org/10.18632/oncotarget.5059
|
| 29111-29128 |
|
| miR146b5p functions as a tumor suppressor by targeting TRAF6 and predicts the prognosis of human gliomas |
|
https://doi.org/10.18632/oncotarget.4895
|
| 29129-29142 |
|
| Global phosphotyrosine survey in triplenegative breast cancer reveals activation of multiple tyrosine kinase signaling pathways |
|
https://doi.org/10.18632/oncotarget.5020
|
| 29143-29160 |
|
| Chitosan nanoparticlemediated delivery of miRNA34a decreases prostate tumor growth in the bone and its expression induces noncanonical autophagy |
|
https://doi.org/10.18632/oncotarget.4971
|
| 29161-29177 |
|
| Colorectal cancerpromoting activity of the senescent peritoneal mesothelium |
|
https://doi.org/10.18632/oncotarget.4932
|
| 29178-29195 |
|
| Upregulation of human cervical cancer protooncogene contributes to hepatitis B virusinduced malignant transformation of hepatocyte by downregulating Ecadherin |
|
https://doi.org/10.18632/oncotarget.5039
|
| 29196-29208 |
|
| H19 non coding RNAderived miR675 enhances tumorigenesis and metastasis of breast cancer cells by downregulating cCbl and Cblb |
|
https://doi.org/10.18632/oncotarget.4976
|
| 29209-29223 |
|
| miR155 identified as antimetastatic by global miRNA profiling of a metastasis model inhibits cancer cell extravasation and colonization in vivo and causes significant signaling alterations |
|
https://doi.org/10.18632/oncotarget.4942
|
| 29224-29239 |
|
| TEL2 suppresses metastasis by downregulating SERPINE1 in nasopharyngeal carcinoma |
|
https://doi.org/10.18632/oncotarget.5074
|
| 29240-29253 |
|
| The metastatic infiltration at the metastasis/brain parenchymainterface is very heterogeneous and has a significant impact on survival in a prospective study |
|
https://doi.org/10.18632/oncotarget.4201
|
| 29254-29267 |
|
| Dynamic cellular and molecular modulations of diabetes mediated head and neck carcinogenesis |
|
https://doi.org/10.18632/oncotarget.4922
|
| 29268-29284 |
|
| A fivemiRNA signature with prognostic and predictive value for MGMT promotermethylated glioblastoma patients |
|
https://doi.org/10.18632/oncotarget.4978
|
| 29285-29295 |
|
| High throughput screening of cytokines chemokines and matrix metalloproteinases in wound fluid induced by mammary surgery |
|
https://doi.org/10.18632/oncotarget.4828
|
| 29296-29310 |
|
| Effect of latent membrane protein 1 expression on overall survival in EpsteinBarr virusassociated cancers: a literaturebased metaanalysis |
|
https://doi.org/10.18632/oncotarget.4906
|
| 29311-29323 |
|
| Identification and characterization of ANO9 in stage II and III colorectal carcinoma |
|
https://doi.org/10.18632/oncotarget.4979
|
| 29324-29334 |
|
| Inactivation of M2 AChR/NFκB signaling axis reverses epithelialmesenchymal transition EMT and suppresses migration and invasion in nonsmall cell lung cancer NSCLC |
|
https://doi.org/10.18632/oncotarget.5004
|
| 29335-29346 |
|
| A method for predicting target drug efficiency in cancer based on the analysis of signaling pathway activation |
|
https://doi.org/10.18632/oncotarget.5119
|
| 29347-29356 |
|
| Positive feedback loop of hepatomaderived growth factor and βcatenin promotes carcinogenesis of colorectal cancer |
|
https://doi.org/10.18632/oncotarget.4982
|
| 29357-29374 |
|
| Hexokinase and phosphofructokinase activity and intracellular distribution correlate with aggressiveness and invasiveness of human breast carcinoma |
|
https://doi.org/10.18632/oncotarget.4910
|
| 29375-29387 |
|
| 18Ffluorodeoxyglucose FDG PET/CT after two cycles of neoadjuvant therapy may predict response in HER2negative but not in HER2positive breast cancer |
|
https://doi.org/10.18632/oncotarget.5001
|
| 29388-29395 |
|
| Critical role of phosphorylation of serine 165 of YBX1 on the activation of NFκB in colon cancer |
|
https://doi.org/10.18632/oncotarget.5120
|
| 29396-29412 |
|
| The PTTG1targeting miRNAs miR329 miR300 miR381 and miR655 inhibit pituitary tumor cell tumorigenesis and are involved in a p53/PTTG1 regulation feedback loop |
|
https://doi.org/10.18632/oncotarget.5003
|
| 29413-29427 |
|
| Exposure to airborne PM25 suppresses microRNA expression and deregulates target oncogenes that cause neoplastic transformation in NIH3T3 cells |
|
https://doi.org/10.18632/oncotarget.5005
|
| 29428-29439 |
|
| TRAILmediated killing of acute lymphoblastic leukemia by plasmacytoid dendritic cellactivated natural killer cells |
|
https://doi.org/10.18632/oncotarget.4984
|
| 29440-29455 |
|
| Inhibition of DNArepair genes Ercc1 and Mgmt enhances temozolomide efficacy in gliomas treatment: a preclinical study |
|
https://doi.org/10.18632/oncotarget.4909
|
| 29456-29468 |
|
| Characterization of the metastatic phenotype of a panel of established osteosarcoma cells |
|
https://doi.org/10.18632/oncotarget.5177
|
| 29469-29481 |
|
| Inhibition of autophagy potentiates pemetrexed and simvastatininduced apoptotic cell death in malignant mesothelioma and nonsmall cell lung cancer cells |
|
https://doi.org/10.18632/oncotarget.5022
|
| 29482-29496 |
|
| Deoxypodophyllotoxin suppresses tumor vasculature in HUVECs by promoting cytoskeleton remodeling through LKB1AMPK dependent Rho A activatio |
|
https://doi.org/10.18632/oncotarget.4985
|
| 29497-29512 |
|
| Dietary prevention of Helicobacter pyloriassociated gastric cancer with kimchi |
|
https://doi.org/10.18632/oncotarget.4897
|
| 29513-29526 |
|
| MiR497 suppresses angiogenesis and metastasis of hepatocellular carcinoma by inhibiting VEGFA and AEG1 |
|
https://doi.org/10.18632/oncotarget.5012
|
| 29527-29542 |
|
| Capsaicin triggers immunogenic PEL cell death stimulates DCs and reverts PELinduced immune suppression |
|
https://doi.org/10.18632/oncotarget.4911
|
| 29543-29554 |
|
| Methylomics analysis identifies ZNF671 as an epigenetically repressed novel tumor suppressor and a potential noninvasive biomarker for the detection of urothelial carcinoma |
|
https://doi.org/10.18632/oncotarget.4986
|
| 29555-29572 |
|
| Stathmin 1 inhibition amplifies ruxolitinibinduced apoptosis in JAK2V617F cells |
|
https://doi.org/10.18632/oncotarget.4998
|
| 29573-29584 |
|
| S100P interacts with integrin α7 and increases cancer cell migration and invasion in lung cancer |
|
https://doi.org/10.18632/oncotarget.4987
|
| 29585-29598 |
|
| A conserved RAD6MDM2 ubiquitin ligase machinery targets histone chaperone ASF1A in tumorigenesis |
|
https://doi.org/10.18632/oncotarget.5011
|
| 29599-29613 |
|
| RPS3 regulates melanoma cell growth and apoptosis by targeting Cyto C/Ca2+/MICU1 dependent mitochondrial signaling |
|
https://doi.org/10.18632/oncotarget.4868
|
| 29614-29625 |
|
| CAVEOLIN1 expression in brain metastasis from lung cancer predicts worse outcome and radioresistance irrespective of tumor histotype |
|
https://doi.org/10.18632/oncotarget.4988
|
| 29626-29636 |
|
| Cyclooxygenase2 in tumorassociated macrophages promotes breast cancer cell survival by triggering a positivefeedback loop between macrophages and cancer cells |
|
https://doi.org/10.18632/oncotarget.4936
|
| 29637-29650 |
|
| Regulation and functional significance of CDC42 alternative splicing in ovarian cancer |
|
https://doi.org/10.18632/oncotarget.4865
|
| 29651-29663 |
|
| Antiangiogenic efficacy of 5′triphosphate siRNA combining VEGF silencing and RIGI activation in NSCLCs |
|
https://doi.org/10.18632/oncotarget.4869
|
| 29664-29674 |
|
| CD151α3β1 integrin complexes are prognostic markers of glioblastoma and cooperate with EGFR to drive tumor cell motility and invasion |
|
https://doi.org/10.18632/oncotarget.4896
|
| 29675-29693 |
|
| Differential targeting of the cyclindependent kinase inhibitor p21CIP1/WAF1 by chelators with antiproliferative activity in a range of tumor celltypes |
|
https://doi.org/10.18632/oncotarget.5088
|
| 29694-29711 |
|
| Heat shock factor 1 an inhibitor of nonhomologous end joining repair |
|
https://doi.org/10.18632/oncotarget.5073
|
| 29712-29724 |
|
| CCL2 is transcriptionally controlled by the lysosomal protease cathepsin S in a CD74dependent manner |
|
https://doi.org/10.18632/oncotarget.5065
|
| 29725-29739 |
|
| The phosphorylation status of VASP at serine 322 can be predictive for aggressiveness of invasive ductal carcinoma |
|
https://doi.org/10.18632/oncotarget.4965
|
| 29740-29752 |
|
| The expression pattern of PFKFB3 enzyme distinguishes between inducedpluripotent stem cells and cancer stem cells |
|
https://doi.org/10.18632/oncotarget.4995
|
| 29753-29770 |
|
| Disulfiram anticancer efficacy without copper overload is enhanced by extracellular H2O2 generation: antagonism by tetrathiomolybdate |
|
https://doi.org/10.18632/oncotarget.4833
|
| 29771-29781 |
|
| FOXA1 regulates androgen receptor variant activity in models of castrateresistant prostate cancer |
|
https://doi.org/10.18632/oncotarget.4927
|
| 29782-29794 |
|
| Aberrant reduction of telomere repetitive sequences in plasma cellfree DNA for early breast cancer detection |
|
https://doi.org/10.18632/oncotarget.5083
|
| 29795-29807 |
|
| Double autophagy modulators reduce 2deoxyglucose uptake in sarcoma patients |
|
https://doi.org/10.18632/oncotarget.5060
|
| 29808-29817 |
|
| Agerelated obesity and type 2 diabetes dysregulate neuronal associated genes and proteins in humans |
|
https://doi.org/10.18632/oncotarget.4904
|
| 29818-29832 |
|
| Simvastatin and downstream inhibitors circumvent constitutive and stromal cellinduced resistance to doxorubicin in IGHV unmutated CLL cells |
|
https://doi.org/10.18632/oncotarget.4006
|
| 29833-29846 |
|
| NDRG1 promotes growth of hepatocellular carcinoma cells by directly interacting with GSK3β and Nur77 to prevent βcatenin degradation |
|
https://doi.org/10.18632/oncotarget.4913
|
| 29847-29859 |
|
| ELK1 is upregulated by androgen in bladder cancer cells and promotes tumor progression |
|
https://doi.org/10.18632/oncotarget.5007
|
| 29860-29876 |
|
| Pancreatic cancerderived exosomes transfer miRNAs to dendritic cells and inhibit RFXAP expression via miR2123p |
|
https://doi.org/10.18632/oncotarget.4924
|
| 29877-29888 |
|
| Pretreatment with VEGFRinhibitors reduces interstitial fluid pressure increases intraperitoneal chemotherapy drug penetration and impedes tumor growth in a mouse colorectal carcinomatosis model |
|
https://doi.org/10.18632/oncotarget.5092
|
| 29889-29900 |
|
| NZ51 a ringexpanded nucleoside analog inhibits motility and viability of breast cancer cells by targeting the RNA helicase DDX3 |
|
https://doi.org/10.18632/oncotarget.4898
|
| 29901-29913 |
|
| Alltrans retinoic acid and rapamycin normalize Hutchinson Gilford progeria fibroblast phenotype |
|
https://doi.org/10.18632/oncotarget.4939
|
| 29914-29928 |
|
| Stroma derived COL6A3 is a potential prognosis marker of colorectal carcinoma revealed by quantitative proteomics |
|
https://doi.org/10.18632/oncotarget.4966
|
| 29929-29946 |
|
| Honokiol activates LKB1miR34a axis and antagonizes the oncogenic actions of leptin in breast cancer |
|
https://doi.org/10.18632/oncotarget.4937
|
| 29947-29962 |
|
| Tonantzitlolone cytotoxicity toward renal cancer cells is PKCθ and HSF1dependent |
|
https://doi.org/10.18632/oncotarget.4676
|
| 29963-29974 |
|
| Epigenetic silencing of NTSR1 is associated with lateral and noninvasive growth of colorectal tumors |
|
https://doi.org/10.18632/oncotarget.5034
|
| 29975-29990 |
|
| Combinatorial treatment using targeted MEK and SRC inhibitors synergistically abrogates tumor cell growth and induces mesenchymalepithelial transition in nonsmallcell lung carcinoma |
|
https://doi.org/10.18632/oncotarget.5031
|
| 29991-30005 |
|
| miR146b5p mediates p16dependent repression of IL6 and suppresses paracrine procarcinogenic effects of breast stromal fibroblasts |
|
https://doi.org/10.18632/oncotarget.4933
|
| 30006-30016 |
|
| BaxPGAM5LDrp1 complex is required for intrinsic apoptosis execution |
|
https://doi.org/10.18632/oncotarget.5013
|
| 30017-30034 |
|
| Automated tracking of tumorstroma morphology in microtissues identifies functional targets within the tumor microenvironment for therapeutic intervention |
|
https://doi.org/10.18632/oncotarget.5046
|
| 30035-30056 |
|
| Identification of therapeutic targets in ovarian cancer through active tyrosine kinase profiling |
|
https://doi.org/10.18632/oncotarget.4996
|
| 30057-30071 |
|
| Base excision repairmediated resistance to cisplatin in KRASG12C mutant NSCLC cells |
|
https://doi.org/10.18632/oncotarget.5019
|
| 30072-30087 |
|
| The HGF inhibitory peptide HGP1 displays promising in vitro and in vivo efficacy for targeted cancer therapy |
|
https://doi.org/10.18632/oncotarget.3937
|
| 30088-30101 |
|
| Inhibition of glucose6phosphate dehydrogenase sensitizes cisplatinresistant cells to death |
|
https://doi.org/10.18632/oncotarget.4945
|
| 30102-30114 |
|
| Dissecting the contribution of EBNA3C domains important for EBVinduced Bcell growth and proliferation |
|
https://doi.org/10.18632/oncotarget.5002
|
| 30115-30129 |
|
| Vacciniarelated kinase 1 promotes hepatocellular carcinoma by controlling the levels of cell cycle regulators associated with G1/S transition |
|
https://doi.org/10.18632/oncotarget.4967
|
| 30130-30148 |
|
| Targeting autophagy enhances the antitumoral action of crizotinib in ALKpositive anaplastic large cell lymphoma |
|
https://doi.org/10.18632/oncotarget.4999
|
| 30149-30164 |
|
| RASSF8 regulates progression of cutaneous melanoma through nuclear factorκb |
|
https://doi.org/10.18632/oncotarget.5030
|
| 30165-30177 |
|
| Functional chemical genomic and superenhancer screening identify sensitivity to cyclin D1/CDK4 pathway inhibition in Ewing sarcoma |
|
https://doi.org/10.18632/oncotarget.4903
|
| 30178-30193 |
|
| Membrane associated canceroocyte neoantigen SAS1B/ovastacin is a candidate immunotherapeutic target for uterine tumors |
|
https://doi.org/10.18632/oncotarget.4734
|
| 30194-30211 |
|
| Clinical impact of CD200 expression in patients with acute myeloid leukemia and correlation with other molecular prognostic factors |
|
https://doi.org/10.18632/oncotarget.4901
|
| 30212-30221 |
|
| Histidinerich glycoprotein function in hepatocellular carcinoma depends on its Nglycosylation status and it regulates cell proliferation by inhibiting Erk1/2 phosphorylation |
|
https://doi.org/10.18632/oncotarget.4997
|
| 30222-30231 |
|
| IDH1/2 mutation status combined with Ki67 labeling index defines distinct prognostic groups in glioma |
|
https://doi.org/10.18632/oncotarget.4920
|
| 30232-30238 |
|
| MiRNA10a is upregulated in NSCLC and may promote cancer by targeting PTEN |
|
https://doi.org/10.18632/oncotarget.4972
|
| 30239-30250 |
|
| LDL suppresses angiogenesis through disruption of the HIF pathway via NFκB inhibition which is reversed by the proteasome inhibitor BSc2118 |
|
https://doi.org/10.18632/oncotarget.4943
|
| 30251-30262 |
|
| Nuclear HDAC6 inhibits invasion by suppressing NFκB/MMP2 and is inversely correlated with metastasis of nonsmall cell lung cancer |
|
https://doi.org/10.18632/oncotarget.4749
|
| 30263-30276 |
Clinical Research Papers
|
| Extramural depth of rectal cancer tumor invasion at thinsection MRI: predicting treatment response to neoadjuvant chemoradiation |
|
https://doi.org/10.18632/oncotarget.4623
|
| 30277-30286 |
|
| Survival outcome according to KRAS mutation status in newly diagnosed patients with stage IV nonsmall cell lung cancer treated with platinum doublet chemotherapy |
|
https://doi.org/10.18632/oncotarget.4711
|
| 30287-30294 |
|
| IDH mutation 1p19q codeletion and ATRX loss in WHO grade II gliomas |
|
https://doi.org/10.18632/oncotarget.4497
|
| 30295-30305 |
|
| Integrative proteomic and gene expression analysis identify potential biomarkers for adjuvant trastuzumab resistance: analysis from the Finher phase III randomized trial |
|
https://doi.org/10.18632/oncotarget.5080
|
| 30306-30316 |
|
| Posttreatment plasma EBVDNA positivity predicts early relapse and poor prognosis for patients with extranodal NK/T cell lymphoma in the era of asparaginase |
|
https://doi.org/10.18632/oncotarget.4505
|
| 30317-30326 |
|
| Expression of high affinity folate receptor in breast cancer brain metastasis |
|
https://doi.org/10.18632/oncotarget.4639
|
| 30327-30333 |
|
| Plasma biomarkers of clinical response during chemotherapy plus combination antiretroviral therapy cART in HIV+ patients with advanced Kaposi sarcoma |
|
https://doi.org/10.18632/oncotarget.4571
|
| 30334-30342 |
|
| High casein kinase 1 epsilon levels are correlated with better prognosis in subsets of patients with breast cancer |
|
https://doi.org/10.18632/oncotarget.4850
|
| 30343-30356 |
|
| Identification of prostate cancer biomarkers in urinary exosomes |
|
https://doi.org/10.18632/oncotarget.4851
|
| 30357-30376 |
|
| Implications for determining the optimal treatment for locally advanced rectal cancer in elderly patients aged 75 years and older |
|
https://doi.org/10.18632/oncotarget.4599
|
| 30377-30383 |
|
| 89Zrcetuximab PET imaging in patients with advanced colorectal cancer |
|
https://doi.org/10.18632/oncotarget.4672
|
| 30384-30393 |
|
| Critical role of bevacizumab scheduling in combination with presurgical chemoradiotherapy in MRIdefined highrisk locally advanced rectal cancer: Results of the BRANCH trial |
|
https://doi.org/10.18632/oncotarget.4724
|
| 30394-30407 |
|
| A phase 2 openlabel multicenter study of the longterm safety of siltuximab an antiinterleukin6 monoclonal antibody in patients with multicentric Castleman disease |
|
https://doi.org/10.18632/oncotarget.4655
|
| 30408-30419 |
Retraction
|
| Retraction: Guggulsterone inhibits prostate cancer growth via inactivation of Akt regulated by ATP citrate lyase signaling |
|
https://doi.org/10.18632/oncotarget.6005
|
| 30420 |
Copyright © 2026 Rapamycin Press LLC dba Impact Journals
Oncotarget ® is a registered trademark of Rapamycin Press LLC
Impact Journals ® is a registered trademark of Rapamycin Press LLC
RAPAMYCIN PRESS ® is a registered trademark of Rapamycin Press LLC
